Interferon alfacon-1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfacon-1
Drug Alias Nameinterferonum alfacon-1复合α干扰素Interferon-alpha consensus干扰素Alfacon-1复合干扰素α-1 +[18] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C, ChronicHepatitis CInfluenza, Human
Global Approved IndicationsHepatitis C, ChronicHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/10/06
Country/TerritoryCanadaUnited StatesEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Europe BvKadmon Corporation LlcUniversity Health Network (Uhn)
Active IndicationsN/A
Inactive IndicationsHepatitis C, ChronicHepatitis CInfluenza, Human

Other Information

ATC CodeL03AB09
Related LinksWikipediaDrugBankKEGG